(Q51796582)

12 April 2018

title

Small-cell lung cancer with lymphadenopathy in an 18-year-old female nonsmoker. (English)

1 reference

12 April 2018

1

Kan Yonemori

1 reference

12 April 2018

author name string

Hideo Kunitoh

series ordinal

2

1 reference

12 April 2018

Ikuo Sekine

series ordinal

3

1 reference

12 April 2018

publication date

1 July 2006

1 reference

12 April 2018

Nature Clinical Practice Oncology

published in

1 reference

12 April 2018

volume

3

1 reference

12 April 2018

issue

7

1 reference

12 April 2018

page(s)

399-403; quiz following 403

1 reference

12 April 2018

Microsatellite instability in lung cancer patients 40 years of age or younger

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

Occupational risk factors for lung cancer among young men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

Young lung cancer patients in Japan: different characteristics between the sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Lung cancer in the young

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Risk of lung cancer from tobacco smoking among young women from Europe

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Glutathione pathway genes and lung cancer risk in young and old populations.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Prophylactic cranial irradiation in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Treatment of recurrent small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0534

7 January 2021

Identifiers

DOI

10.1038/NCPONC0534

1 reference

12 April 2018

1 reference

12 April 2018